Measles surge: CDC tallies 416 U.S. cases so far in 2026

The Centers for Disease Control and Prevention updated its measles data page on Jan. 23 to report 416 confirmed cases of measles in the United States so far in 2026, with the tally current as of 12:00 p.m. on Jan. 22. Cases were reported by 14 jurisdictions, including Arizona, and public health officials said outbreaks remain active as agencies track exposures and attempt to limit further spread.

The rapid accumulation of cases early in the year has alarmed health authorities because measles is one of the most contagious viruses known. An infected person can spread the disease to roughly nine of 10 susceptible people they encounter, and the virus lingers in air and on surfaces for hours after an infected person leaves a room. That combination of high transmissibility and remaining pockets of low vaccination coverage creates conditions for clusters of infection to escalate into wider outbreaks.

Measles can cause severe complications, particularly in infants, pregnant people and immunocompromised individuals. The illness typically begins with fever, cough and runny nose, followed by a characteristic rash. Vaccination with the measles-mumps-rubella vaccine, commonly given as MMR, is highly effective and remains the primary tool for preventing spread. Public health experts generally cite a herd immunity threshold of roughly 95 percent to prevent sustained transmission, a level that many communities have not consistently maintained.

State and local health departments have been conducting case investigations, contact tracing and targeted vaccination efforts to contain outbreaks. Measures commonly include identifying exposure sites such as schools and clinics, recommending post-exposure prophylaxis for susceptible contacts, and mounting community vaccination clinics to close immunity gaps. Because data on the current outbreaks are changing daily, health departments are urging clinicians to consider measles in patients with compatible symptoms and to verify vaccination status for those at risk.

The early-season surge underscores broader challenges in U.S. immunization programs. Declines in routine childhood vaccination during the COVID-19 pandemic, combined with vaccine hesitancy and misinformation in some communities, have left enough susceptible people to permit measles chains of transmission. International travel and importations from regions where measles remains endemic continue to seed cases in the United States, making high domestic vaccination coverage essential to prevent local spread.

Public health leaders warn that containing the current outbreaks will require sustained outreach to improve vaccine uptake, clear clinical guidance for recognizing and reporting cases, and resources for local health departments to run vaccination campaigns and manage contact investigations. If efforts do not rapidly increase immunity in affected communities, the outbreaks could expand, placing additional strain on public health systems and risking more severe outcomes among vulnerable populations.

The CDC's updated tally will be followed by further adjustments as new reports arrive and investigations conclude. Health care providers and members of the public seeking vaccination or guidance are advised to consult their state or local health department and the CDC for the most current information and recommendations.